ASTRAZENECA PLC (AZN)
Clinical trial NCT05918042 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2025-07-31 → 2025-05-29 3. primary completion date: 2025-07-31 → 2025-05-29 4. enrollment: not set → 414 participants
Clinical trial NCT05918042 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2025-07-31 → 2025-05-29 3. primary completion date: 2025-07-31 → 2025-05-29 4. enrollment: not set → 414 participants
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical